CH
BMY icon

Canton Hathaway’s Bristol-Myers Squibb BMY Stock Holding History

Canton Hathaway’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$206K Buy
3,395
+125
+4% +$7.29K 0.04% 128
2025
Q4 		$176K Buy
3,270
+1,950
+148% +$93.8K 0.03% 139
2025
Q3 		$60K Hold
1,320
– – 0.01% 195
2025
Q2 		$61K Buy
1,320
+50
+4% +$2.45K 0.01% 186
2025
Q1 		$77K Buy
1,270
+275
+28% +$16K 0.02% 175
2024
Q4 		$56K Buy
995
+300
+43% +$16.8K 0.01% 155
2024
Q3 		$36K Hold
695
– – 0.01% 187
2024
Q2 		$29K Hold
695
– – 0.01% 202
2024
Q1 		$38K Hold
695
– – 0.01% 176
2023
Q4 		$36K Hold
695
– – 0.01% 181
2023
Q3 		$40K Hold
695
– – 0.01% 167
2023
Q2 		$44K Hold
695
– – 0.01% 166
2023
Q1 		$48K Hold
695
– – 0.02% 157
2022
Q4 		$50K Hold
695
– – 0.02% 162
2022
Q3 		$49K Sell
695
-500
-42% -$36.3K 0.02% 153
2022
Q2 		$92K Hold
1,195
– – 0.03% 127
2022
Q1 		$87K Hold
1,195
– – 0.02% 136
2021
Q4 		$75K Sell
1,195
-25,343
-95% -$1.49M 0.02% 157
2021
Q3 		$1.57M Sell
26,538
-4,505
-15% -$297K 0.45% 43
2021
Q2 		$2.07M Sell
31,043
-839
-3% -$54.7K 0.61% 33
2021
Q1 		$2.01M Buy
31,882
+6,582
+26% +$410K 0.64% 29
2020
Q4 		$1.57M Buy
25,300
+9,110
+56% +$560K 0.53% 37
2020
Q3 		$976K Buy
16,190
+10,290
+174% +$619K 0.4% 36
2020
Q2 		$347K Sell
5,900
-940
-14% -$56.2K 0.23% 52
2020
Q1 		$381K Buy
6,840
+940
+16% +$57.5K 0.27% 40
2019
Q4 		$379K Sell
5,900
-870
-13% -$49.8K 0.19% 61
2019
Q3 		$343K Buy
6,770
+6,270
+1,254% +$295K 0.19% 61
2019
Q2 		$23K Hold
500
– – 0.01% 171
2019
Q1 		$23K Hold
500
– – 0.01% 170
2018
Q4 		$26K Hold
500
– – 0.02% 130
2018
Q3 		$31K Buy
+500
New +$29.7K 0.02% 117

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Canton Hathaway's BMY Position: Q1 2026 in Review

Canton Hathaway increased its Bristol-Myers Squibb (BMY) stake by 3.8% in Q1 2026, buying an estimated $7.29K and bringing the position to 3,395 shares worth $206K. The position accounts for 0.04% of the portfolio, ranked #128.

Canton Hathaway first reported a position in BMY in Q3 2018 and has held it in 31 quarters since. The position peaked at $2.07M in Q2 2021. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Canton Hathaway held 3,395 shares of Bristol-Myers Squibb worth $206K as of Q1 2026.
  • Canton Hathaway bought 125 Bristol-Myers Squibb shares in Q1 2026, an estimated $7.29K.
  • Bristol-Myers Squibb made up 0.04% of Canton Hathaway's portfolio in Q1 2026, its #128 holding.
  • Canton Hathaway first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 31 quarters since.
  • Canton Hathaway's Bristol-Myers Squibb position peaked at $2.07M in Q2 2021.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Canton Hathaway's 13F filing for Q1 2026, filed 24 Apr 2026.